Utah Medical Marijuana Program Nears 109,000 Patients as January Sales Top $15.9 Million

Key Points
  • Utah’s medical marijuana program has grown steadily, with 108,879 active patients and over 1,000 medical providers as of January; Salt Lake County holds the largest number of cardholders.
  • The majority of patients are adults aged 31 to 50 (49%), with significant representation from both younger adults (21-30) and seniors over 65, while patients under 21 are minimal.
  • Sales totaled nearly $16 million in January, led by vape cartridges and pens, which outpaced flower and edibles, highlighting changing consumer preferences.
  • Supply infrastructure is robust, with large biomass harvests, extensive processing, and a comprehensive delivery network ensuring statewide patient access; regulatory oversight remains active with few compliance issues reported.

Utah’s medical marijuana program continues to expand at a steady pace, with the state reporting 108,879 patients holding active medical cannabis cards as of January, roughly 1,000 more than the previous month, according to a new report released by the Utah Department of Health and Human Services. The report shows Utah now has over 1,000 registered recommending medical providers and more than 2,200 licensed industry agents working across cultivation, processing, pharmacy, and courier roles, highlighting how large the infrastructure behind the program has become in just a few years. Salt Lake County alone accounts for 44,972 patients, with Utah County (16,728), Davis County (12,032), and Weber County (11,249) also representing significant concentrations of cardholders.

Patient age data reveals the program is primarily driven by adults between 31 and 50 years old, who make up nearly 49% of all cardholders. Another 21.87% are between 21 and 30, while patients over 65 account for 11.04%, demonstrating that the program serves both working-age adults and seniors at notable rates. Patients under 21 make up less than 0.1% of the total population.

Purchasing activity is especially telling. In the last 30 days alone, 60,488 patients made at least one purchase, 34,985 made two or more purchases, and 21,876 made three or more. Over a 90-day window, more than 83,000 patients purchased at least once, and over 41,500 made four or more purchases, underscoring how consistently patients rely on the program for ongoing access.

When it comes to what patients are buying, vape cartridges and pens clearly lead the market. January sales across all tracked product categories totaled $15,902,800, with $7,636,200 coming from cartridges and pens alone, far outpacing flower at $5,213,100 and infused edibles at $2,821,600. Non-edible infused products such as balms and patches accounted for just $112,200, while non-medicated devices made up $119,700. The long-term sales chart in the report shows cartridges steadily widening the gap over other categories over the past several years.

On the supply side, cultivators harvested over 8.5 million grams of wet cannabis biomass in January across 294 planting batches, with more than 8,600 plants harvested during the month. Processors converted large portions of this into finished flower, trim, fresh/frozen material for extraction, and derivative products such as cartridges and edibles. Pharmacies received over 180,000 vape products and more than 100,000 edible units from processors during the month.

Utah’s delivery network is also extensive. Multiple companies now offer rural, urban, and courier delivery across nearly every county in the state, ensuring patients in remote areas have access without traveling long distances to a pharmacy. The delivery and pickup maps show Salt Lake County as the highest-volume region, but consistent activity across rural counties as well.

Regulatory oversight remains active. During the month, the state conducted 35 inspections across pharmacies, processors, and labeling operations. Most facilities had no violations, although a handful of pharmacy and processor infractions were recorded related to inventory control, labeling, and operational requirements. Lab testing during the period showed 448 products passing compliance testing with just four failures.

The cardholder growth chart shows a steady, almost linear rise in active patients since the program’s inception in 2020, with renewals per month consistently in the 6,000 to 8,000 range over the past half year. The data indicates not just enrollment growth, but strong retention among existing patients who continue renewing their cards and purchasing regularly.

The full report can be found by clicking here (PDF).